| Name | SJF620 |
|---|---|
| Synonyms |
3-[5-[2-[2-[2-[4-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]ethoxy]ethoxy]ethoxy]-1,3-dihydro-1-oxo-2H-isoindol-2-yl]-2,6-piperidinedione
SJF-620,SJF620 3-(5-{2-[2-(2-{4-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}ethoxy)ethoxy]ethoxy}-1-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-2,6-dione 2,6-Piperidinedione, 3-[5-[2-[2-[2-[4-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]ethoxy]ethoxy]ethoxy]-1,3-dihydro-1-oxo-2H-isoindol-2-yl] |
| Description | SJF620 is a potent PROTAC BTK degrader with a DC50 of 7.9 nM[1]. |
|---|---|
| Related Catalog | |
| Target |
Cereblon |
| In Vitro | SJF620 is a PROTAC that retains potent degradation of BTK in cellular assays with a DC50 of 7.9 nM in NAMALWA cells line[1]. |
| In Vivo | SJF620 has a super pharmacokinetic profile in mice (1 mg/kg; i.v.) with half life (t1/2) of 1.64 h. SJF620 exhibits a significantly better pharmacokinetic profile than MT802[1]. |
| References |
| Molecular Formula | C41H44N8O7 |
|---|---|
| Molecular Weight | 760.84 |
| Storage condition | -20°C |